Pembrolizumab Bulk Immunological Product from Japan
A mixed preparation of pembrolizumab (Keytruda) monoclonal antibody for immunotherapy in melanoma and lung cancer, supplied in bulk with formulation excipients. It is not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
Duty Rate — Japan → Canada
0%
Import Tips
• Provide evidence of the product's composition to the CBSA
• Ensure it is not for retail sale
• Check if the product requires a Drug Identification Number (DIN) from Health Canada